Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Topiramate Use in Adolescents

Contraindications and Precautions

  • Topiramate is contraindicated in pregnancy or potential pregnancy without reliable contraception, as it is teratogenic and associated with cleft lip/palate, according to the American Diabetes Association 1, 2
  • The American Academy of Neurology recommends monthly pregnancy testing for females of reproductive potential taking topiramate 3
  • The medication is contraindicated in pregnancy and during breastfeeding, as stated by the National Institute of Neurological Disorders and Stroke 4, 5

Clinical Considerations

  • For migraine prophylaxis in adolescents ages 12-17, topiramate is used in practice, though effectiveness has not been definitively proven in clinical trials due to high placebo response rates, according to the American Headache Society 4, 6
  • The American Academy of Child and Adolescent Psychiatry states that evidence is equivocal in children and adolescents for irritability and mood disorders, and it is not recommended as a primary treatment 3

Monitoring and Side Effects

  • Cognitive impairment, paresthesia, and metabolic acidosis are common side effects requiring monitoring, as reported by the American Diabetes Association 3, 5
  • Regular serum bicarbonate monitoring is essential due to metabolic acidosis risk, according to the National Institute of Diabetes and Digestive and Kidney Diseases 3

Drug Interactions

  • Topiramate decreases the efficacy of combined oral contraceptives (COCs), and adolescent females using hormonal contraception require alternative or additional contraceptive methods, as stated by the American Academy of Pediatrics 7
  • The medication can cause menstrual spotting in women taking birth control pills due to altered metabolism of estrogen and progestins, according to the Endocrine Society 8

Key Safety Warnings

  • Gradual discontinuation is required, as abrupt cessation may increase seizure risk, according to the American Epilepsy Society 3
  • Monitor blood pressure and heart rate, especially during initial titration, as recommended by the American Heart Association 3

Dosing Approach

  • For migraine prophylaxis, typical maintenance doses range from 50-100 mg daily, as stated by the American Headache Society 6